Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

From Alzheimer's prevention to weight-loss dominance, Novo bets on innovation and share repurchases amid Medicare pressure.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Minnesota Attorney General Keith Ellison says he will announce "a major development in his litigation against the three largest insulin manufacturers" on Monday morning.

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.